EMCDDA Home
  • EN
Search

Tips: Click on a column heading to order the results.Use the filters to limit the number of results.

More help>>

Displaying results 1–10 of 47 where Type of intervention is Pharmacologically assisted treatment

<< previous next >>

Filter results:

Project description Intervention type Evaluation type Setting Target group Country Quality level
Title: Dialectic Behaviour Therapy For Female Borderline Patients With And Without Substance Use Problems
Summary: This study describes the difference in the dropout rate and drug use of dialectical behaviour therapy for female borderline patients with and without substance misuse problems. One year after treatment the dropout rate of participants in dialectical behaviour therapy was lower than for those who were involved in standard treatment. >>
treatment outcome evaluation adults Netherlands 1
Title: Effects Of Medical Heroin Co-prescription For Treatment-refractory Chronic Addicts
Summary: This study looks at the positive and negative effects of a one year heroin prescription to treatment refractory chronic opiate addicts initially participating unsuccessfully in a methadone programme. This study shows that medical heroin prescription appears to be feasible and safe for treatment refractory chronic opiate addicts. >>
treatment outcome evaluation, impact evaluation, process evaluation adults Netherlands 2
Title: Young And Addicted: The Usefulness And Necessity Of Integrated, Intersectoral Inpatient Treatment
Summary: The evaluation study looks at the effectiveness of treatment for young people aged between 13 and 18 in Bauhuus in the region of Groningen. >>
treatment outcome evaluation children/young people Netherlands 1
Title: Relapse Prevention (CRA) With Naltrexone Maintenance For Opiate Addicts
Summary: The purpose of this study was to explore the effects of naltrexone maintenance combined with psychosocial treatment; namely CRA, the Community reinforcement Approach. >>
treatment outcome evaluation adults Netherlands 1
Title: Substitution Treatment Unit A of Athens
Summary: The programme is designed for those IV heroin users whose needs were so far unmet by other programmes. The programme's objectives are defined as follows: abstinence, harm reduction, high quality medical and psychosocial services, and rehabilitation. Methadone substitution is only one of the interventions in an intergraded programme, which also includes medical, psychiatric, psychosocial, and social support. >>
treatment outcome evaluation adults Greece 1
Title: GRÜNER KREIS: A Treatment Facility For Adolescents
Summary: Gruner Kreis a treatment facility for adolescents - An institution devoted to the rehabilitation and integration of people suffering from addiction. "Grüner Kreis" also provides special treatment for addicted parents and their children in a separate institution. >>
treatment outcome evaluation children/young people Austria 1
Title: Beyond the Line
Summary: The Verein Dialog (Vienna) developed a special programme for cocaine users, which was tested and evaluated from 2008 to 2009 and integrated in the routine work afterwards. The programme is based on a low-threshhold approach and focuses on flexibility and short term interventions. >>
treatment outcome evaluation, process evaluation outpatient adults Austria 2
Title: Efficacy of a Smoking Cessation Programme in a Smoking Cessation Service
Summary: The programme can be provided as individual and group. The individual treatment programme consists of 10 consultations; the first is the baseline and the remaining 9 are the follow-up. The baseline consultation lasts between 30 and 40 min, and at the end patients choose Quit-date. During this visit, which is always given by an Specialist on Smoking Treatment, the clinical and smoking history is taken, and various tests are performed: measurement of CO in expired air, spirometry and measurement of cotinine levels in body fluids. The follow-up visits are held at 1st, 2nd, 4th, 8th, 10th and 12th weeks, then 4th, 6th and 12th months after quit-date, and are all independently conducted by Healthcare Professionals Specialist on Smoking Treatment. These consultations are to control withdrawal symptoms, provide cognitive behavioural treatment and prescribe drug therapy. Different tests are also performed, e.g. measurement of CO in expired air and measurement of cotinine levels in body fluids. Three times a week, the patients’ situation is considered in a clinical session held by all members of the Smoking Cessation Service, where each case is discussed and appropriate decisions are taken. The group treatment programme consists of 9 sessions. The first takes place a few days before quit-date and lasts approximately 80-90 min. During this session, the patients choose their quit-date and receive advice in preparing for it. They are then informed about the basics of withdrawal. In addition, various tests are performed: measurement of CO in expired air, spirometry and measurement of cotinine levels in body fluids. The remaining sessions are held at 1st, 2nd, 4th, 8th, 10th, and 12th weeks, then at 4th and 5th months after quit-date. These sessions help to control withdrawal and prescribe drug therapy, as well as explain the different cognitive behavioural techniques to patients. Various tests are also performed: measurement of CO in expired air and measurement of cotinine levels in body fluids. The prescribed treatment is a combination of pharmacological and psychological treatment. The drug therapy consists of the different types of Nicotine Replacement Therapy used in Spain, bupropion or varenicline, or a combination of both. The psychotherapy consists of the following activities: self-monitoring, identifying high-risk situations, coping strategies, cognitive behavioural therapy and intra-treatment support. All patients attending the UET are referred by a doctor. Individual or group therapy is decided in the Smoking Cessation Service by health personnel or by patient preference. Results From 2003 to 2008 a total of 21,418 medical consultations took place. These consultations provided help to 3,920 smokers to stop smoking. The group of attended smokers consisted of more or less equal numbers of men and women, their mean age was 47,83, 67% of them suffered from smoking-related disorders, 43% suffered from psychiatric co-morbidities and 21% of them suffered from other addictions. The average number of cigarettes smoked daily was 28, and they suffered from high nicotine dependence (over 77% smoked their first cigarette within 30 min after waking up). The vast majority of patients seen (97.6%) received both pharmacological treatment and psychotherapy, either individually or in groups. Only 2.4% of them received just psychological treatmet. Treatment was individual for 87% of the patients and by group for the rest. Efficacy data at 6th, 12th, 36th, and 57th months follow-up were 58,5%, 54,9%, 42% and 35%, respectevely. >>
treatment outpatient general population Spain 2
Title: Methadone Maintenance Programme, Drug Treatment Unit, Asturias Mental Health Services
Summary: The project investigates the long term effectiveness of methadone maintenance treatment over a 6-year period. The results show that treatment is successful, in particular the treatment allows more attention to be given to other client problems like their mental health. >>
treatment outcome evaluation, impact evaluation adults Spain 1
Title: Programme to improve access to treatment for opiate users in Castile and Leon
Summary: Based in Castile and Leon, the main objectives of the regional methadone maintenance treatment programme is to improve rural access to the service and to reduce waiting lists. The principle is to bring the services administering methadone as close as possible to users and improve and reinforce care facilities handling large numbers of cases. >>
treatment process evaluation general population, adults Spain 1

Displaying results 1–10 of 47 where Type of intervention is Pharmacologically assisted treatment

<< previous next >>

Survey

Dear visitor,

We're currently conducting a short survey of this resource (EDDRA: Exchange on Drug Demand Reduction Action). The survey will take no more than 2 minutes and we would be really grateful for your contribution.

No, thanks — maybe some other time

Yes, I'll take the survey!

Many thanks,

The EDDRA team

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00

More contact options >>

Page last updated: Friday, 20 January 2012